Related Experiment Video

Updated: Jun 30, 2026

Differentiation of Functional Osteoclasts from Human Peripheral Blood CD14+ Monocytes
11:52

Differentiation of Functional Osteoclasts from Human Peripheral Blood CD14+ Monocytes

Published on: January 27, 2023

The Death Receptor 3-TNF-like protein 1A pathway drives adverse bone pathology in inflammatory arthritis

Melanie Jane Bull1, Anwen Siân Williams, Zarabeth Mecklenburgh

  • 1Department of Medical Biochemistry and Immunology, School of Medicine, Heath Park, Cardiff CF14 4XN, Wales, UK.

The Journal of Experimental Medicine
|October 1, 2008
PubMed

Insights

The Death Receptor 3 (DR3) pathway exacerbates rheumatoid arthritis (RA) bone destruction. Blocking this pathway protected mice from joint damage, suggesting DR3-TL1A is a potential therapeutic target for RA.

Area of Science:

  • Immunology
  • Rheumatology
  • Orthopedics

Background:

  • Rheumatoid arthritis (RA) is a chronic inflammatory joint disease causing cartilage and bone destruction.
  • Death Receptor 3 (DR3), a TNF receptor superfamily member, is implicated in RA pathogenesis.

Purpose of the Study:

  • To investigate the role of the DR3-TL1A pathway in RA-associated bone pathology.
  • To evaluate the therapeutic potential of targeting this pathway in murine arthritis models.

Main Methods:

  • Utilized experimental antigen-induced arthritis (AIA) and collagen-induced arthritis (CIA) mouse models.
  • Assessed histopathological changes, bone erosion, and osteoclastogenesis.
  • Administered anti-TL1A monoclonal antibody (mAb) treatment.

Main Results:

  • DR3 knockout mice showed reduced AIA pathology, particularly protection from subchondral bone erosions.
  • TL1A exacerbated arthritis in a DR3-dependent manner and directly promoted osteoclastogenesis in vitro.
  • Anti-TL1A mAb treatment protected CIA model mice from systemic RA disease.

Conclusions:

  • The DR3-TL1A pathway is a key regulator of joint destruction in experimental arthritis.
  • Targeting the DR3-TL1A pathway offers a promising therapeutic strategy for inflammatory joint diseases like RA.

Related Concept Videos

The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
NF-kB-dependent Signaling Pathway02:26

NF-kB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...